SpaceWar.com - Your World At War
Iraq security forces seize 12 million benzhexol pills
Baghdad, May 5 (AFP) May 05, 2023
Iraqi security forces said Friday they had seized 12 million pills of the antispasmodic drug benzhexol, used in the treatment of Parkinson's disease but also abused as a hallucinogen.

National Security officers recovered the haul from a warehouse in east Baghdad in an operation in which they also made six arrests.

Iraqi security forces have intensified anti-narcotics operations in recent months, with several high-profile seizures reported.

Sharing borders with Syria as well as Kuwait and Saudi Arabia, Iraq has served as a major conduit for traffickers of captagon, an amphetamine which is primarily produced in Syria but has its largest market in the wealthy Gulf states.


ADVERTISEMENT




Space News from SpaceDaily.com
NASA picks Firefly Aerospace for ambitious 2029 lunar rover and instrument delivery
Team led by MDA Space to define future of Canadian lunar vehicle program
Lunar soil machine developed to build bricks using sunlight

24/7 Energy News Coverage
Designing compact drones to safely navigate air ducts
Map Africa project to deliver continentwide geospatial data for 54 nations
The complex relationship between fusion fuel and lithium walls

Military Space News, Nuclear Weapons, Missile Defense
Boeing X37B Spaceplane Prepares for Eighth Orbital Test Mission
Israel military intercepts Huthi missile fired from Yemen; Gaza civil defence says Israel strikes kill 30
BlackSky secures next stage of Navy contract for optical satellite link upgrades

24/7 News Coverage
Cosmic dust particles reveal snapshot of Earth's ancient air
Spire to Provide ESA with Satellite Weather Data for European Research
Gaza seen from above: debris and darkness



All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.